These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 6611569)

  • 1. Ca2+ uptake and energy supply of sheep heart mitochondria in presence of some calcium antagonists.
    Leblondel G; Allain P
    Res Commun Chem Pathol Pharmacol; 1984 Jun; 44(3):499-502. PubMed ID: 6611569
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Action of bepridil, a new calcium channel blocker on oxidative phosphorylation, oligomycin-sensitive adenosine triphosphatase activity, swelling, Ca++ uptake and Na+-induced Ca++ release processes of rabbit heart mitochondria in vitro.
    Matlib MA
    J Pharmacol Exp Ther; 1985 May; 233(2):376-81. PubMed ID: 3158732
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of bepridil on Ca2+ uptake by cardiac mitochondria.
    Younes A; Schneider JM
    Biochem Pharmacol; 1984 Apr; 33(8):1363-6. PubMed ID: 6231932
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative study of bepridil and nicardipine action on respiration and calcium transport in mitochondria.
    Tari C; Fournier N; Ducet G; Crevat A; Albengres E; Urien S; Tillement JP
    Int J Clin Pharmacol Ther Toxicol; 1987 Jan; 25(1):26-30. PubMed ID: 2951341
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protective effect of some calcium antagonists against mitochondrial calcium injury.
    Tabouy L; Chauvet-Monges AM; Salducci MD; Crevat A
    Int J Tissue React; 1994; 16(5-6):221-8. PubMed ID: 7558666
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of bepridil on heart mitochondrial membrane and the isolated rat heart preparation.
    Fuchs J; Mainka L; Reifart N; Zimmer G
    Arzneimittelforschung; 1986 Feb; 36(2):209-12. PubMed ID: 2938592
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Slow calcium channel blockers and calmodulin. Effect of felodipine, nifedipine, prenylamine and bepridil on cardiac sarcolemmal calcium pumping ATPase.
    Lamers JM; Cysouw KJ; Verdouw PD
    Biochem Pharmacol; 1985 Nov; 34(21):3837-43. PubMed ID: 2933041
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential actions of calcium antagonists on calcium binding to cardiac sarcolemma.
    Pang DC; Sperelakis N
    Eur J Pharmacol; 1982 Jul; 81(3):403-9. PubMed ID: 6981516
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibitor effects of diltiazem, nicardipine, nifedipine and verapamil on the norepinephrine-induced contractions of the canine saphenous vein in calcium-free medium.
    Saïag B; Milon D; Bentue-Ferrer D; Allain H; Rault B; Van den Driessche J
    Res Commun Chem Pathol Pharmacol; 1994 Mar; 83(3):255-69. PubMed ID: 8008975
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of bepridil on calcium release from rat heart mitochondria.
    Schneider JM; Berson G; Cruz C; Younes A
    Pharmacol Res Commun; 1988 Mar; 20(3):183-94. PubMed ID: 3260385
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protection of ischemic hearts by Ca2+ antagonists.
    Watts JA
    J Mol Cell Cardiol; 1986 Oct; 18 Suppl 4():71-5. PubMed ID: 3491215
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nifedipine, diltiazem, bepridil and verapamil uptakes into cardiac and smooth muscles.
    Pang DC; Sperelakis N
    Eur J Pharmacol; 1983 Feb; 87(2-3):199-207. PubMed ID: 6601581
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacology of calcium antagonists.
    Schwartz A; Matlib MA; Balwierczak J; Lathrop DA
    Am J Cardiol; 1985 Mar; 55(7):3C-7C. PubMed ID: 3872055
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective inhibition of Na+-induced Ca2+ release from heart mitochondria by diltiazem and certain other Ca2+ antagonist drugs.
    Vághy PL; Johnson JD; Matlib MA; Wang T; Schwartz A
    J Biol Chem; 1982 Jun; 257(11):6000-2. PubMed ID: 6176579
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro and in vivo effects of R023-6152 on heart mitochondrial calcium and energy metabolism.
    Medh JD; Rex KA; Benedict CR; Sordahl LA
    J Cardiovasc Pharmacol; 1991 Oct; 18(4):473-7. PubMed ID: 1724522
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Uptake of calcium antagonistic drugs into muscles as related to their lipid solubilities.
    Pang DC; Sperelakis N
    Biochem Pharmacol; 1984 Mar; 33(5):821-6. PubMed ID: 6608945
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Myocardial cellular mechanism of action of calcium antagonists].
    Ferrari R; Boffa GM; Ciampalini G; Ceconi C
    Cardiologia; 1985 Feb; 30(2):77-89. PubMed ID: 3905004
    [No Abstract]   [Full Text] [Related]  

  • 18. [Experimental substantiation for the application of calcium channel blockers in vibration disease].
    Vorob'eva VV; Shabanov PD
    Med Tr Prom Ekol; 2013; (2):37-41. PubMed ID: 23785817
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the effects of bepridil and diltiazem upon globally ischemic rat hearts.
    Watts J; Maiorano P; Harwell T
    Eur J Pharmacol; 1987 Jan; 134(1):25-33. PubMed ID: 3493911
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical pharmacology of calcium inhibitors].
    Singlas E; Martre H; Taburet AM
    Arch Mal Coeur Vaiss; 1985 Nov; 78 Spec No():15-22. PubMed ID: 3937500
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.